Shenzhen YHLO Biotech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shenzhen YHLO Biotech Co., Ltd.

Why is Shenzhen YHLO Biotech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -17.89% and Operating profit at -39.30% over the last 5 years

The company has declared negative results for the last 9 consecutive quarters

The company has declared negative results in Mar 23 after 2 consecutive negative quarters
NET PROFIT(HY) At CNY 62.04 MM has Grown at -61.39%
INTEREST(HY) At CNY 9.77 MM has Grown at 35.57%
OPERATING CASH FLOW(Y) Lowest at CNY 286.13 MM

With ROE of 6.88%, it has a expensive valuation with a 3.06 Price to Book Value

Over the past year, while the stock has generated a return of -18.54%, its profits have fallen by -46.6%

Below par performance in long term as well as near term

Along with generating -18.54% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shenzhen YHLO Biotech Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shenzhen YHLO Biotech Co., Ltd.

-41.88%

-1.82

24.54%

China Shanghai Composite

16.78%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-5.32%

EBIT Growth (5y)

-31.49%

EBIT to Interest (avg)

50.60

Debt to EBITDA (avg)

0.13

Net Debt to Equity (avg)

0.09

Sales to Capital Employed (avg)

0.54

Tax Ratio

11.06%

Dividend Payout Ratio

51.47%

Pledged Shares

Institutional Holding

ROCE (avg)

24.88%

ROE (avg)

18.68%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.01

EV to EBIT

34.71

EV to EBITDA

14.53

EV to Capital Employed

1.92

EV to Sales

3.18

PEG Ratio

Dividend Yield

ROCE (Latest)

5.54%

ROE (Latest)

3.26%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 522.51 MM

RAW MATERIAL COST(Y)

Fallen by -41.32% (YoY

-32What is not working for the Company

INTEREST(HY)

At CNY 12.7 MM has Grown at 46.77%

PRE-TAX PROFIT(Q)

At CNY 22.52 MM has Fallen at -55.17%

NET PROFIT(Q)

At CNY 19.31 MM has Fallen at -59.56%

NET SALES(HY)

At CNY 921.74 MM has Grown at -10.41%

ROCE(HY)

Lowest at 1.14%

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.01 times

INTEREST COVERAGE RATIO(Q)

Lowest at 745.52

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.31 times

OPERATING PROFIT(Q)

Lowest at CNY 32.86 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 8.26 %

Here's what is working for Shenzhen YHLO Biotech Co., Ltd.

Operating Cash Flow

Highest at CNY 522.51 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Raw Material Cost

Fallen by -41.32% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shenzhen YHLO Biotech Co., Ltd.

Interest

At CNY 12.7 MM has Grown at 46.77%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY 22.52 MM has Fallen at -55.17%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 19.31 MM has Fallen at -59.56%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest Coverage Ratio

Lowest at 745.52

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Sales

At CNY 921.74 MM has Grown at -10.41%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Debtors Turnover Ratio

Lowest at 3.01 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Operating Profit

Lowest at CNY 32.86 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 8.26 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 1.31 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio